Mucosal T cell memory to pathogens
- Institution
- UNIVERSITY OF MINNESOTA, MN
- Principal investigator
- David Masopust
- Funding
- $571K
- Duration
- 2010–2029
Moonbase score
Still being scored
Abstract
Project Summary T cell immunity may be exploited through vaccination, immunomodulating therapies, and engineered adoptive cell therapies to immunize against or control infections and cancer. However repeated or prolonged stimulation can result in T cell dysfunction and senescence which impairs protective immunity or allows disease progression. Establishing numerically robust, durable, and functional T cell immunity and preventing or reversing T cell exhaustion remain substantial goals in immunology that have significant clinical ramifications. Our preliminary data demonstrates that repeated stimulation, even when punctuated by periods of rest, can result in senescence. However, we also show that this fate can be avoided, allowing indefinite boosting across multiple mouse lifetimes, while preserving function and durability. Additional preliminary data indicates that T cells can adapt to become inured to exhaustion. The goals of this proposal are to determine the underlying mechanisms that permit T cells to undergo indefinite clonal expansion while avoiding functional exhaustion or proliferative senescence. Successful execution of the proposal will inform our understanding of the regulation of immunological memory, vaccine development, and immune therapies for chronic diseases. .
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF MINNESOTA
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of MinnesotaNot yet scored
Effect of aging and senescent cells
David Masopust · $541K · 2024–2029
- NIH · University of MinnesotaNot yet scored
Using an in vivo multi-lifetime model to test mechanisms of aging
David Masopust · $637K · 2024–2029
- NIH · University of MinnesotaNot yet scored
Resident Memory T Cells
David Masopust · $700K · 2020–2030